Modulation of Cognitive Control Signals in Prefrontal Cortex by Rhythmic Transcranial Magnetic Stimulation

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT03828734
Collaborator
National Institute of Mental Health (NIMH) (NIH)
58
1
2
9.3
6.3

Study Details

Study Description

Brief Summary

Purpose: In this study, the investigators will provide causal evidence for the role of alpha and theta oscillations in cognitive control.

Participants: Participants must be healthy, between the ages of 18 and 35, right handed, able to provide informed consent, willing to comply with all study procedures, and be available for the duration of the study, speak and understand English.

Procedures: Alpha and theta brain oscillations will be measured and then entrained using frequency specific rhythmic TMS during a retrospective cued cognitive control task.

Condition or Disease Intervention/Treatment Phase
  • Device: Theta TMS
  • Device: Alpha TMS
  • Device: Arrhythmic TMS
N/A

Detailed Description

Neural oscillations are proposed to be a mechanism of coordinating information processing across distributed regions of cortex. Different neural oscillations may correspond to different underlying neural computations. Noninvasive brain stimulation allows experimenters to modulate specific neural oscillations by targeting particular frequency bands. By collecting simultaneous electroencephalography (EEG), rhythmic transcranial magnetic stimulation (TMS) has been previously demonstrated to entrain neural oscillations at the frequency of stimulation. Furthermore, when the frequency of entrained neural oscillations is matched to the frequency of endogenous activity in a cognitive task, the brain stimulation improves behavioral performance. Therefore, noninvasive brain stimulation is a promising tool for improving cognition by inducing optimal neural activity via externally applied electromagnetic fields; e.g. cognitive control improvements.

Previous evidence has implicated neural activity in the alpha band (8-12 Hz) in information suppression and activity in the theta band (4-7 Hz) in information prioritization. Cognitive control task paradigms have been shown to elicit distinct activity in both of these bands. In this task, the stimuli are lateralized to the right and left visual field during encoding. After a short delay, a cue informs participants which stimuli (right or left) will be tested. Previous evidence found that alpha activity in parietal cortex is generated contralateral to irrelevant stimuli-supporting the role of alpha in information suppression-while theta activity in frontal cortex increases with the number of stimuli to be remembered-supporting the role of theta in information prioritization.

For the current study, the investigators propose to deliver rhythmic trains of TMS in either alpha frequency, theta frequency, or an arrhythmic control to modulate neural processing during a cognitive control task. By collecting simultaneous EEG with TMS, the investigators will be able to measure the entrained oscillations from rhythmic TMS. The goal of this experiment is to enhance the observed theta and alpha activity that is seen with the successful prioritization and suppression of information. To provide causal evidence that parietal cortex generates alpha activity and frontal cortex generates theta activity, the investigators will apply rhythmic TMS stimulation to two scalp locations: the anterior middle frontal gyrus and inferior intraparietal sulcus. By applying alpha frequency, theta frequency, and arrhythmic TMS at each location, the investigators will be able to examine the causal relationship of frontal theta oscillations in information prioritization and parietal alpha oscillations in information suppression.

Study Design

Study Type:
Interventional
Actual Enrollment :
58 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Modulation of Alpha and Theta Oscillations in a Cognitive Control Retrospective Cue Task With Frequency Specific Rhythmic Transcranial Magnetic Stimulation
Actual Study Start Date :
Feb 13, 2019
Actual Primary Completion Date :
Nov 22, 2019
Actual Study Completion Date :
Nov 22, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: TMS to frontal cortex followed by TMS to parietal cortex

Participants will receive TMS while performing a cognitive control task. In their first stimulation session, the TMS coil will be placed over the frontal cortex on the scalp. In their second session, the TMS coil will be placed over the parietal cortex on the scalp. During every session, subjects receive Theta TMS, Alpha TMS, and Arrhythmic TMS.

Device: Theta TMS
TMS will be administered at the frequency of each subject's endogenous theta oscillation (4-7Hz)
Other Names:
  • MagProX100
  • Device: Alpha TMS
    TMS will be administered at the frequency of each subject's endogenous alpha oscillation (8-12 Hz)
    Other Names:
  • MagProX100
  • Device: Arrhythmic TMS
    TMS will be administered arrhythmically; i.e. a sequence of pulses with randomized timing
    Other Names:
  • MagProX100
  • Experimental: TMS to parietal cortex followed by TMS to frontal cortex

    Participants will receive TMS while performing a cognitive control task. In their first stimulation session, the TMS coil will be placed over the parietal cortex on the scalp. In their second session, the TMS coil will be placed over the frontal cortex on the scalp. During every session, subjects receive Theta TMS, Alpha TMS, and Arrhythmic TMS.

    Device: Theta TMS
    TMS will be administered at the frequency of each subject's endogenous theta oscillation (4-7Hz)
    Other Names:
  • MagProX100
  • Device: Alpha TMS
    TMS will be administered at the frequency of each subject's endogenous alpha oscillation (8-12 Hz)
    Other Names:
  • MagProX100
  • Device: Arrhythmic TMS
    TMS will be administered arrhythmically; i.e. a sequence of pulses with randomized timing
    Other Names:
  • MagProX100
  • Outcome Measures

    Primary Outcome Measures

    1. Number of Remembered Items [1 week]

      Participants make a button press on a keyboard to indicate if the probed items are matched or non-matched to the items held in memory after a retrospective cue is presented. The investigators calculate the percent correct for non-match conditions, defined as the hit rate, and the percent incorrect for match conditions, defined as the false alarm rate. The number of remembered items, often referred to as working memory capacity, is calculated as the number of items to be remembered (2, 3, or 4) times the hit rate minus the false alarm rate, divided by one minus the false alarm rate. The range of values is 0 to 4 where larger values mean better performance. For TMS to frontal cortex, working memory capacity is reported when the participant was cued to the right. For TMS to parietal cortex, working memory capacity is reported when the participant was cued to the left.

    2. Amplitude of Neural Oscillations [1 week]

      The electrical activity of the brain is recorded during performance of the task and brain stimulation. The investigators will perform Morlet wavelet convolution on the recorded electrical signal to calculate the amplitude of neural oscillations in the frequency bands: theta (4-7 hertz) and alpha (8-12 hertz). The amplitude of neural oscillations is reported during the second half of stimulation in the region that is being stimulated. The amplitude is normalized for each participant as the percent change from the amplitude during the baseline period (before the task begins). For TMS to frontal cortex the amplitude of theta oscillations are reported and for TMS to parietal cortex the amplitude of alpha oscillations are reported.

    3. Response Time [1 week]

      Participants make a button press on a keyboard to indicate if the probe items are matched or non-matched to the items held in memory after a retrospective cue is presented. The investigators will calculate the response time of this choice as the difference between the time of the button press and presentation of the probe. For TMS to frontal cortex, response time is reported when the participant was cued to the right. For TMS to parietal cortex, response time is reported when the participant was cued to the left.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 35 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy

    • Between the ages of 18 and 35

    • Right handed

    • Able to provide informed consent

    • Willing to comply with all study procedures

    • Available for the duration of the study

    • Speak and understand English.

    Exclusion Criteria:
    • Attention Deficit Hyperactivity Disorder (currently under treatment)

    • Neurological disorders and conditions, including, but not limited to: History of epilepsy Seizures (except childhood febrile seizures) -Dementia

    • History of stroke

    • Parkinson's disease

    • Multiple sclerosis

    • Cerebral aneurysm

    • Brain tumors

    • Medical or neurological illness or treatment for a medical disorder that could interfere with study participation (e.g., unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment)

    • Prior brain surgery -Any brain devices/implants, including cochlear implants and aneurysm clips -Cardiac pacemaker -Any other implanted electronic device -History of current traumatic brain injury -(For females) Pregnancy or breast feeding -Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of North Carolina at Chapel Hill Chapel Hill North Carolina United States 27516

    Sponsors and Collaborators

    • University of North Carolina, Chapel Hill
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Flavio Frohlich, PhD, University of North Carolina, Chapel Hill

    Study Documents (Full-Text)

    More Information

    Publications

    Responsible Party:
    University of North Carolina, Chapel Hill
    ClinicalTrials.gov Identifier:
    NCT03828734
    Other Study ID Numbers:
    • 18-1789
    • R01MH111889
    First Posted:
    Feb 4, 2019
    Last Update Posted:
    Nov 19, 2020
    Last Verified:
    Dec 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title TMS to Frontal Cortex Followed by TMS to Parietal Cortex TMS to Parietal Cortex Followed by TMS to Frontal Cortex
    Arm/Group Description Participants will receive transcranial magnetic stimulation (TMS) while performing a cognitive control task. In the first stimulation session, the TMS coil will be placed over the frontal cortex on the scalp. In the second session, the TMS coil will be placed over the parietal cortex on the scalp. During every session, participants receive Alpha TMS, Theta TMS, and Arrhythmic TMS. Participants will receive TMS while performing a cognitive control task. In their first stimulation session, the TMS coil will be placed over the parietal cortex on the scalp. In their second session, the TMS coil will be placed over the frontal cortex on the scalp. During every session, participants receive Alpha TMS, Theta TMS, and Arrhythmic TMS.
    Period Title: Baseline
    STARTED 32 26
    COMPLETED 32 26
    NOT COMPLETED 0 0
    Period Title: Baseline
    STARTED 32 26
    COMPLETED 29 25
    NOT COMPLETED 3 1
    Period Title: Baseline
    STARTED 29 25
    COMPLETED 25 25
    NOT COMPLETED 4 0
    Period Title: Baseline
    STARTED 25 25
    COMPLETED 25 24
    NOT COMPLETED 0 1
    Period Title: Baseline
    STARTED 25 24
    COMPLETED 25 24
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title All Participants
    Arm/Group Description Participants will receive TMS while performing a cognitive control task. In one stimulation session, the TMS coil will be placed over the frontal cortex on the scalp. In another session, the TMS coil will be placed over the parietal cortex on the scalp. During every session, participants receive Alpha TMS, Theta TMS, and Arrhythmic TMS.
    Overall Participants 58
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    22.2
    (3.83)
    Sex: Female, Male (Count of Participants)
    Female
    39
    67.2%
    Male
    19
    32.8%
    Ethnicity (NIH/OMB) (Count of Participants)
    Hispanic or Latino
    9
    15.5%
    Not Hispanic or Latino
    48
    82.8%
    Unknown or Not Reported
    1
    1.7%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    Asian
    16
    27.6%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    Black or African American
    3
    5.2%
    White
    31
    53.4%
    More than one race
    3
    5.2%
    Unknown or Not Reported
    5
    8.6%
    Region of Enrollment (participants) [Number]
    United States
    58
    100%
    Number of Remembered Items (number of remembered items) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [number of remembered items]
    1.8039
    (0.4988)
    Response Time (seconds) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [seconds]
    0.8225
    (0.1605)

    Outcome Measures

    1. Primary Outcome
    Title Number of Remembered Items
    Description Participants make a button press on a keyboard to indicate if the probed items are matched or non-matched to the items held in memory after a retrospective cue is presented. The investigators calculate the percent correct for non-match conditions, defined as the hit rate, and the percent incorrect for match conditions, defined as the false alarm rate. The number of remembered items, often referred to as working memory capacity, is calculated as the number of items to be remembered (2, 3, or 4) times the hit rate minus the false alarm rate, divided by one minus the false alarm rate. The range of values is 0 to 4 where larger values mean better performance. For TMS to frontal cortex, working memory capacity is reported when the participant was cued to the right. For TMS to parietal cortex, working memory capacity is reported when the participant was cued to the left.
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    54 participants were randomized into the experiment arms. 5 participants did not complete both arms and are excluded from analysis. In addition, data from 2 participant was corrupted and 5 participants were excluded due to poor task performance. Analysis was run on 42 participants.
    Arm/Group Title TMS to Frontal Cortex TMS to Parietal Cortex
    Arm/Group Description Participants receive TMS to frontal cortex while performing a cognitive control task. During every session, participants receive Theta TMS, Alpha TMS, and Arrhythmic TMS. Participants receive TMS to parietal cortex while performing a cognitive control task. During every session, participants receive Theta TMS, Alpha TMS, and Arrhythmic TMS.
    Measure Participants 42 42
    Theta TMS
    1.863
    (0.613)
    1.754
    (0.524)
    Alpha TMS
    1.796
    (0.495)
    1.797
    (0.572)
    Arrhythmic TMS
    1.803
    (0.381)
    1.864
    (0.469)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection TMS to Frontal Cortex, TMS to Parietal Cortex
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value 0.263
    Comments
    Method ANOVA
    Comments
    2. Primary Outcome
    Title Amplitude of Neural Oscillations
    Description The electrical activity of the brain is recorded during performance of the task and brain stimulation. The investigators will perform Morlet wavelet convolution on the recorded electrical signal to calculate the amplitude of neural oscillations in the frequency bands: theta (4-7 hertz) and alpha (8-12 hertz). The amplitude of neural oscillations is reported during the second half of stimulation in the region that is being stimulated. The amplitude is normalized for each participant as the percent change from the amplitude during the baseline period (before the task begins). For TMS to frontal cortex the amplitude of theta oscillations are reported and for TMS to parietal cortex the amplitude of alpha oscillations are reported.
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    54 participants were randomized into the experiment arms. 5 participants did not complete both arms and are excluded from analysis. In addition, data from 2 participant was corrupted and 5 participants were excluded due to poor task performance. Analysis was run on 42 participants.
    Arm/Group Title TMS to Frontal Cortex TMS to Parietal Cortex
    Arm/Group Description Participants receive TMS to frontal cortex while performing a cognitive control task. During every session, participants receive Theta TMS, Alpha TMS, and Arrhythmic TMS. Participants receive TMS to parietal cortex while performing a cognitive control task. During every session, participants receive Theta TMS, Alpha TMS, and Arrhythmic TMS.
    Measure Participants 42 42
    Theta TMS
    1.443
    (1.227)
    -0.201
    (0.505)
    Alpha TMS
    0.489
    (0.412)
    0.241
    (1.045)
    Arrhythmic TMS
    0.944
    (0.705)
    -0.132
    (0.600)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection TMS to Frontal Cortex, TMS to Parietal Cortex
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value <0.000001
    Comments
    Method ANOVA
    Comments
    3. Primary Outcome
    Title Response Time
    Description Participants make a button press on a keyboard to indicate if the probe items are matched or non-matched to the items held in memory after a retrospective cue is presented. The investigators will calculate the response time of this choice as the difference between the time of the button press and presentation of the probe. For TMS to frontal cortex, response time is reported when the participant was cued to the right. For TMS to parietal cortex, response time is reported when the participant was cued to the left.
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    54 participants were randomized into the experiment arms. 5 participants did not complete both arms and are excluded from analysis. In addition, data from 2 participant was corrupted and 5 participants were excluded due to poor task performance. Analysis was run on 42 participants.
    Arm/Group Title TMS to Frontal Cortex TMS to Parietal Cortex
    Arm/Group Description Participants receive TMS to frontal cortex while performing a cognitive control task. During every session, participants receive Theta TMS, Alpha TMS, and Arrhythmic TMS. Participants receive TMS to parietal cortex while performing a cognitive control task. During every session, participants receive Theta TMS, Alpha TMS, and Arrhythmic TMS.
    Measure Participants 42 42
    Theta TMS
    0.728
    (0.157)
    0.714
    (0.154)
    Alpha TMS
    0.711
    (0.162)
    0.710
    (0.162)
    Arrhythmic TMS
    0.720
    (0.155)
    0.717
    (0.166)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection TMS to Frontal Cortex, TMS to Parietal Cortex
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value 0.399
    Comments
    Method ANOVA
    Comments

    Adverse Events

    Time Frame Adverse events were systematically assessed after the 3 hour session for both arms. Each session was 1 week apart. Thus, adverse events were monitored for approximately 1 week.
    Adverse Event Reporting Description
    Arm/Group Title TMS to Frontal Cortex TMS to Parietal Cortex
    Arm/Group Description Participants receive TMS to frontal cortex while performing a cognitive control task. During every session, participants receive Theta TMS, Alpha TMS, and Arrhythmic TMS. Participants receive TMS to parietal cortex while performing a cognitive control task. During every session, participants receive Theta TMS, Alpha TMS, and Arrhythmic TMS.
    All Cause Mortality
    TMS to Frontal Cortex TMS to Parietal Cortex
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/53 (0%) 0/50 (0%)
    Serious Adverse Events
    TMS to Frontal Cortex TMS to Parietal Cortex
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/53 (0%) 0/50 (0%)
    Other (Not Including Serious) Adverse Events
    TMS to Frontal Cortex TMS to Parietal Cortex
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 25/53 (47.2%) 25/50 (50%)
    Ear and labyrinth disorders
    Ringing or buzzing noise 0/53 (0%) 0 0/50 (0%) 0
    General disorders
    Sleepiness 10/53 (18.9%) 10 9/50 (18%) 9
    Trouble concentrating 11/53 (20.8%) 11 6/50 (12%) 6
    Dizziness 2/53 (3.8%) 2 0/50 (0%) 0
    Flickering lights 0/53 (0%) 0 1/50 (2%) 1
    Skin and subcutaneous tissue disorders
    Headache 11/53 (20.8%) 11 11/50 (22%) 11
    Neck pain 1/53 (1.9%) 1 1/50 (2%) 1
    Scalp pain 9/53 (17%) 9 8/50 (16%) 8
    Tingling 3/53 (5.7%) 3 2/50 (4%) 2
    Burning sensation 3/53 (5.7%) 3 2/50 (4%) 2
    Local redness 2/53 (3.8%) 2 2/50 (4%) 2
    Itching 0/53 (0%) 0 2/50 (4%) 2

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Justin Riddle, PhD
    Organization University of North Carolina at Chapel Hill
    Phone 919-966-4755
    Email justin_riddle@med.unc.edu
    Responsible Party:
    University of North Carolina, Chapel Hill
    ClinicalTrials.gov Identifier:
    NCT03828734
    Other Study ID Numbers:
    • 18-1789
    • R01MH111889
    First Posted:
    Feb 4, 2019
    Last Update Posted:
    Nov 19, 2020
    Last Verified:
    Dec 1, 2019